FDA Okays Affymax Anemia Drug Omontys - Update
(RTTNews) - Affymax Inc. (AFFY: News ) said Tuesday the US Food and Drug Administration has approved its investigational injection Omontys for treatment of anemia in chronic kidney disease patients on dialysis. Following the news, Affymax shares surged ...
Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection ...
Affymax Wins Approval of Drug for Anemic Kidney Patients
FDA Approves Affymax's Omontys To Treat Anemia